Clinical Trials Directory

Trials / Conditions / Liquid Biopsy

Liquid Biopsy

30 registered clinical trials studyying Liquid Biopsy16 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Dia
NCT07467109
M.D. Anderson Cancer Center
RecruitingUrinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Ca
NCT07475403
Tianjin Medical University Second HospitalPhase 2
Not Yet RecruitingLiquid Biopsy in Early Colorectal Lesions
NCT07319104
University Hospital, Montpellier
RecruitingUsing Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma
NCT07441499
Tianjin Medical University Second Hospital
RecruitingGuiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Ca
NCT07187635
Tianjin Medical University Second HospitalN/A
RecruitingGuiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Blad
NCT07180212
Tianjin Medical University Second HospitalN/A
RecruitingThe Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of Hig
NCT07130578
Tianjin Medical University Second Hospital
Not Yet RecruitingClinical Studies of Endometrial Cytology and Cervical Methylation Assays in Endometrial Cancer Screening and F
NCT06672341
Yulan Ren
RecruitingFrench Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)
NCT06287814
University Hospital, Montpellier
Not Yet RecruitingFrench Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)
NCT06287723
University Hospital, Montpellier
RecruitingFrench Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)
NCT06287749
University Hospital, Montpellier
WithdrawnInvestigation of Urinary Biomarkers for the Detection of Prostate Cancer
NCT05454371
Novosanis NVN/A
RecruitingLiver Cancer and Immunotherapy in the Liquid Biopsy Era
NCT05810402
University Hospital, MontpellierN/A
UnknownA Liquid Biopsy Diagnostic Techniques for Endometriosis
NCT05749341
Tongji Hospital
UnknownInvestigation of Urinary Biomarkers for the Detection of Breast Cancer
NCT05453591
Novosanis NVN/A
UnknownMONOCENTRIC PERSPECTIVE STUDY: USE OF LIQUID BIOPSY WITH DIAGNOSTIC IMAGING
NCT05623241
University of Campania Luigi Vanvitelli
CompletedBlood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
NCT05383872
InSightecN/A
RecruitingThe Jinling Cohort
NCT06011694
Nanjing Shihejiyin Technology, Inc.
UnknownCombing a Deep Learning-Based Radiomics With Liquid Biopsy for Preoperative and Non-invasive Diagnosis of Glio
NCT05536024
Second Affiliated Hospital of Nanchang University
RecruitingVersatile Ampification Single-Molecule Detection in Liquid Biopsy
NCT05940311
Regina Elena Cancer Institute
CompletedEarly Detection of Five Common Cancers Using the ctDNA Analysing Test
NCT05227261
Gene Solutions
RecruitingObservational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papil
NCT05918510
Regina Elena Cancer Institute
UnknownHost DNA Methylation for Endometrial Cancer Screening
NCT05290415
Lei Li
Active Not RecruitingA Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Tr
NCT04852653
University Hospital, Bordeaux
Active Not RecruitingBRAINFUL (BRAIN Tumor Focused Ultrasound-enabled Liquid Biopsy) Trial
NCT04940507
University Health Network, TorontoN/A
UnknownCell-free DNA Methylation for Endometrial Cancer
NCT04651738
Lei LiN/A
UnknownCell-free DNA Methylation for Epithelial Ovarian Cancer
NCT04651946
Lei LiPhase 2
UnknownEvaluation Protocols for Isolation of Analytes From Urine for Future Oncology Applications
NCT05453604
Novosanis NVN/A
UnknownBiobanking and New Biomolecular Metrics
NCT05906277
Regina Elena Cancer InstituteN/A
RecruitingProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI)
NCT05221372
Erasmus Medical Center